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ABSTRACT
Nucleotide sequencing of the vaccinia virus SalI F DNA fragment identified an open reading frame
of 552 amino acids encoding a protein of 63.3 kDa. The deduced amino acid sequence shares 30%
identity with S. pombe and S. cerevisiae DNA ligases with homology strongest near the carboxy
terminus and around the lysine residue required for ligase-adenylate formation. Prokaryotic DNA
ligases are poorly related to the vaccinia sequence. The initiation codon of the ORF forms part of
a late transcriptional initiation sequence TAAATG and is preceded by two overlapping early
transcriptional termination signals, '1T1'T'1'1'I7AT. Nonetheless, RNA mapping showed that the ligase
gene is transcribed early during infection and the 5' end of the mRNA maps to the TAAATG motif.
The possible roles of a DNA ligase in vaccinia virus DNA replication and recombination are discussed.
INTRODUCTION
Vaccinia virus is an orthopoxvirus, a group of viruses which transcribe and replicate their
large double stranded DNA genomes in the cytoplasm of infected cells (1). This replication
site distinguishes poxviruses from many other DNA viruses which replicate in the nucleus
and which mostly use endogenous nuclear enzymes for transcription and replication.
Cytoplasmic replication requires that the enzymes for these processes are provided by the
infecting virus and consequently poxviruses encode many enzymes involved in nucleic
acid metabolism. Thus, they provide an excellent system for studying transcription, DNA
replication and recombination in a eukaryotic cell. Poxviruses encode and package a multi-
subunit DNA-dependent RNA polymerase (2-6) and enzymes to cap, methylate and
polyadenylate mRNA (7-10). For DNA metabolism the virus packages a topoisomerase
(11-12), nicking-joining enzyme (13-14) and single stranded-specific DNAase (15).
Within the infected cell a DNA-dependent DNA polymerase (16-19), hetero-dimeric
ribonucleotide reductase (20-22), thymidine kinase (23 -25) and DNA ligase (26,27) are
expressed. The single strand-specific DNAase, nicking-joining enzyme and DNA ligase
have not been proven to be virus encoded.
DNA ligases and the genes encoding them have been identified in E. coli, bacteriophages
T4 and T7 and yeasts S. cerevisiae and S. pombe (28-32). In these organisms the DNA
ligase is an essential enzyme involved in DNA replication, recombination and repair
(reviewed in 33). The genes encoding mammalian DNA ligases have not been identified
although there has been considerable biochemical characterisation of the enzymes (reviewed
in 34). In this report the structure of a vaccinia virus gene encoding a polypeptide of 63.3
kDa which has high amino acid sequence homology to DNA ligases of yeasts and limited
homology to prokaryotic DNA ligases is presented. Transcriptional analyses demonstrate
that the gene is transcribed early during infection. The high degree of homology to both
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yeast DNA ligases particularly near the carboxy terminus may aid the identification and
cloning of mammalian DNA ligase genes via use of synthetic peptides or oligonucleotides.
MATERIALS AND METHODS
Nucleotide sequencing
The 13.4 kb Sall F fragment of vaccinia virus (strain WR) was isolated from cosmid 6,
which contains virus DNA derived from a rifampicin resistant mutant (35), and was cloned
into pUC13. The Sall fragment was separated from plasmid sequences and self-ligated
with T4 DNA ligase. Circular molecules were randomly sheared by sonication, end-repaired
with T4 DNA polymerase and Klenow enzyme and fragments of greater than 300
nucleotides cloned into SmaI cut Ml3mpl8. Single stranded DNA was prepared and
sequenced using the dideoxynucleotide chain termination method (36), using [35S]-dATP
and buffer gradient polyacrylamide gels (37). For further details see (38).
Computer analysis
Nucleotide sequence data were read from authoradiographs by sonic digitiser and assembled
into contiguous sequences using programmes DBAUTO and DBUTIL (39,40) on a VAX
8350 computer. The consensus sequence was translated in 6 frames using programmes
ORFFILE and DELIB (M. Boursnell, Institute of Animal Health, Houghton, UK.). Open
reading frames were compared against SWISSPROT protein database and against our own
database of vaccinia amino acid sequences using programme FASTP (41). Alignments
of multiple protein sequences were performed using programme MULTALIGN (42).
RNA preparation
Early or late virus mRNA was prepared from human TK- 143 cells infected with vaccinia
virus strain WR at 30 plaque forming units per cell as described (43).
Northern analysis
Denatured RNA samples were electrophoresed through agarose gels, transferred to
nitrocellulose membranes and probed with single stranded [32P]-labelled DNA probes as
described (43).
SI nuclease mapping of RNA
RNA samples (10 Ag) were mixed with 90 /g tRNA and a 365 bp ClaI-BclI DNA fragment[32P]-labelled at the 5' terminal phosphate of the BclI site. Nucleic acid was ethanol
precipitated, redissolved in 30 Itl hybridization buffer (80% dionized formamide, 0.4 M
NaCl, 1 mM EDTA (pH 8.0), 40 mM PIPES), denatured at 72°C for 15 min and hybridized
overnight at 30°C. 300 units of Sl nuclease were added in 0.3 ml 0.56 M NaCl, 100
mM sodium acetate (pH 4.6), 9 mM ZnSO4, 20 ,ug/ml denatured carrier DNA and
incubated for 1 h at 30°C. The reaction was stopped with 4 tl 0.25 M EDTA, nucleic
acid extracted with phenol/chloroform and precipitated with ethanol. Samples were
electrophoresed on a 12% polyacrylamide gel in TBE buffer.
Preparation ofprime cut probe
Single stranded DNA from M13 clone 3F, which contains vaccinia DNA from entirely
within the SalF 15R sequence, was annealed with sequencing primer and incubated with
Klenow enzyme, 10 yCi [32P]-labelled dCTP and 0.2 mM dGTP, dATP and dCTP for
15 min at 25°C, then 0.2 mM dCTP was added and incubation continued for 15 min.
The product was cut with EcoRI and Sall and the digests electrophoresed on a 6%
polyacrylamide gel in TBE. The labelled, single stranded DNA fragment was detected
by brief autoradiography and eluted from crushed acrylamide slice in 500 mM ammonium
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Figure 1 Location and direction of transcription of DNA ligase gene within the vaccinia virus genome. A. Vaccinia
virus HindUI restriciton map. B. The 13.4 kb Sall F restriction fragment is expanded and the positions of EcoRI
(E) SmaI(S) restriction sites are indicated. C. A 3300 bp EcoRI-SmaI fragment is expanded showing the position
of the DNA ligase gene (arrow), the position of [32P]-labelled probe used for SI nuclease mapping and the
positions of EcoRI (E), ClaI (C), BclI (Bc), BglII (B) and SmaI (S) restriction sites.
acetate, 10 mM magnesium acetate, 1 mM EDTA, 0.1% SDS and 10 jig/ml tRNA overnight
at 37°C.
Primer e-xtension analyses
An oligonucleotide 5' CCGGGAAGCAATAGCTTAATG 3' was 5'-labelled with
-y[32P]-ATP using polynucleotide kinase and hybridized to denatured RNA samples as
for Si nuclease analysis. Hybridized nucleic acid was recovered by ethanol precipitation
and incubated with avian myeloblastosis virus reverse transcriptase as described (44).
RESULTS
Figure 1 shows the position of the SalI F fragment within the vaccinia virus genome. This
fragment was sequenced using the random shotgun method (38) and a contiguous DNA
sequence of 13,411 nucleotides with an average character density of 6.1 was obtained.
The complete sequence will be published elsewhere. Translation of this sequence detected
more than 20 ORFs of greater than 66 amino acids and which fitted the codon usage of
established vaccinia genes. The position and direction of transcription of the largest ORF
(SalF 15R) is indicated in Figure 1 and the nucleotide sequence and deduced amino acid
sequence are shown in Figure 2. This ORF maps between 7625 and 9280 nucleotides from
the left end of the SalI F fragment and encodes a polypeptide of 552 amino acids with
a predicted molecular weight of 63.3 kD.
The ATG codon at the beginning of SalF 15R is part of a conserved motif (TAAATG)
which is found at the transcriptional initiation site of most late genes (45,46). Immediately
upstream is the sequence TTTTTTTAT which represents two overlapping, early,
transcriptional termination signals (47). The next early transcriptional termination signal
is 2730 nucleotides downstream, 1060 nucleotides beyond the end of SalF 15R. Interestingly,
the sequence TTTT-T-TT-lNT is found just upstream of the TAAATG motif within two
strongly expressed late poxvirus promoters. The cowpox virus gene encoding an abundant
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160 kDa protein found in type A inclusion bodies contains TTTTTTTAT separated from
TAAATG by AA (48,49) and the vaccinia virus gene encoding an 11 kD core basic protein
has the sequence TT YlTTTCT six nucleotides upstream of the TAAATG motif (50). These
sequences suggested that the SalF 15R gene might be transcribed late during infection.
Transcriptional analyses
Virus mRNA produced during the early or late phase of infection was analysed first by
Northern blotting with a single stranded DNA probe derived from entirely within the coding
sequence of SalF 15R. The probe was complementary to the nucleotide sequence shown
in Figure 2 and the result is shown in Figure 3A. Early during infection a major transcript
of approximately 3000 nucleotides and a minor transcript of approximately 4000 nucleotides
are produced (lane 1). These correspond to the sizes of transcripts initiating close to the
beginning of SalF 15R and terminating at the T5NT motifs 2730 or 3790 nucleotides
downstream, allowing for addition of poly A tails of up to 200 nucleotides. Surprisingly,
there is no T5NT motif near the end of SalF 15R so that the mRNAs include SalF 16R
and SalF 17R coding sequences and are therefore potentially bi- or tricistronic. Late during
infection there is a very small amount of the 3000 nucleotide transcript and also a faint
smear of RNA between 2-4,000 nucleotides (lane 2). The discrete size of the 3 kb transcript
suggests that it is residual early RNA since late vaccinia mRNAs are heterogeneous in
size (1).
The SI nuclease technique was used to precisely locate the 5' ends of the mRNAs (51)
(Figure 3B). A 365 nucleotide ClaI-BclI fragment labelled with 32P at the 5' end of the
Bcdl site was used as probe (see Figure 1). The DNA fragments protected from S1 nuclease
by hybridization to early (lane 2), late (lane 3) or mock-infected (lane 4) RNA are shown
in Figure 3B. The sequencing ladder (lanes TCGA) is from an unrelated M13 clone extended
from the universal primer with Klenow enzyme and isotopically labelled with [35S]-dATP.
Early RNA protected a major cluster of DNA fragments 113-122 nucleotides long with
the strongest signal at 118 and 119. There are other minor clusters of protected fragments
38-39, 74-77 and 89-91 nucleotides long visible on longer exposure. Collectively all
these minor bands represent only a very small fraction of total protected DNA. The
5'-labelled nucleotide of the probe is 119 nucleotides downstream of the A nucleotide in
the translational initiation codon and, therefore, the major 5' end of the early mRNA maps
to within, or just downstream of, the TAAATG motif. The positions of the RNA start
sites are marked in Figure 2. The S1 nuclease technique can underestimate the length of
RNA by a few nucleotides so it is likely that the majority of the early transcripts initiate
within the TAAATG motif. Late RNA contains a small amount of transcripts initiating
at the same position but it is uncertain if this reflects true late transcription or a small
residual amount of early RNA that was also noted in Northern analysis.
The presence of early RNA initiating at, or close to, a potential late transcription initiation
site raised the possibility that these RNAs contain 5' poly A sequences of up to 35
nucleotides, a feature of late vaccinia mRNAs (52,53). This was addressed by primer
Figure 2 Nucleotide sequence of a 1776 nucleotide region of the 13.4 kb Sall F fragment. The deduced sequence
of a 552 amino acid open reading frame is shown. The positions of potential transcription control signals are
underlined. The major and minor 5' ends of early mRNAs mapped by SI nuclease protection are indicated by
open triangles or arrow heads, respectively. Exclamation marks indicate the positions of the 5' ends of early
mRNAs mapped by primer extension. Nucleotides complementary to the oligonucleotide used for primer extension
are marked with an asterisk. Numbers indicate either the nucleotide number, starting 60 nucleotides upstream
of the open reading frame, or amino acid number starting from the first methionine.
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Figure 3 Transcriptional analyses. A. Northern analysis of virus mRNA. RNA extracted 6 hrs after infection
in the presence of cycloheximide (early, lane 1) or 10 hrs after infection without drug (late, lane 2) or from
uninfected cells (lane 3) was resolved by electrophoresis through denaturing agarose gels, transferred by blotting
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extension analysis using an oligonucleotide complementary to nucleotides 119-139
(inclusive) downstream of the A of the translation initiation codon. The position of this
oligonucleotide is indicated in Figure 2 and the results of this analysis are shown in Figure
3C. With early RNA (lane 2), primer extended products of 141-146 nucleotides are
produced. These map at, or just upstream of, the TAAATG motif and the SI nuclease
start site. The tight clustering of the primer extended products at a position approximately
5 nucleotides upstream of the 5' ends as determined by SI nuclease protection, indicated
that the early mRNAs do not contain 5' poly A sequences of heterogeneous length. The
slight difference in length of the primer extended products versus the SI nuclease protected
fragments may be attributable to SI digestion of a few terminal nucleotides. Alternatively,
the true 5' end of the mRNA may contain a few (4 or 5) A residues between the cap
structure and the AUG. No extended product was produced by reverse transcription of
late RNA (lane 3). This experiment was performed with a different preparation of late
RNA than used in Northern and SI experiments and the absence of any extended product
supports the conclusion that a small amount of early virus mRNA remained in the late
RNA preparation used for Northern and SI analyses.
Analysis of the open reading frame
Comparison of the amino acid sequence of SalF 15R with our database of vaccinia virus
proteins using programme FASTP (41) found no strong matches. However, a search of
the protein database SWISSPROT revealed extensive homology to DNA ligase of
Saccharomyces cerevisiae (31). An optimised FASTP score of 527 was obtained (KTUP
of 1) and the two proteins had 30% amino acid identity over a 412 amino acid region.
A similar degree of homology exists between SalF 15R and Saccharomyces pombe DNA
ligase (32) although fission yeast S. pombe and the budding yeast S. cerevisiae are
evolutionarily divergent. Only weak homology was detected with bacteriophage T4 and
T7 and E. coli DNA ligases. An alignment of the amino acid sequences of DNA ligases
from yeasts and vaccinia virus is shown in Figure 4. This alignment shows that the amino-
terminal region of the vaccinia protein is divergent from both yeast sequences and there
are regions which are absent in vaccinia but present in both yeasts. The latter point is
reflected in the predicted sizes of the proteins, with vaccinia DNA ligase (63.3 kD) being
considerably smaller than DNA ligases of S. pombe (86.2 kD) and S. cerevisiae (84.8
kD). The yeast DNA ligases are also least conserved in the amino terminal region. In
contrast, in the carboxy-terminal region the three sequences are almost colinear and have
extensive amino acid identity and conservative changes. The presumed catalytic lysine at
the ATP binding site (marked with asterisk) is conserved in all these sequences and as
to a nitrocellulose membrane and probed with a [32P]-labelled, prime-cut, single stranded DNA fragment
complementary in sequence to an internal region of the DNA ligase gene shown in Figure 2. An autoradiograph
is shown. The positions of double stranded DNA molecular weight markers are indicated in kilobases. B. SI
nuclease protection mapping of 5' ends of mRNA. A 365 bp ClaI-BclI fragment, [32P]-labelled at the 5' end
of the BclI site, was hybridized with early (lane 2) or late (lane 3) vaccinia virus mRNA or mock infected RNA
(lane 4). After digestion with S1 nuclease, DNA fragments were resolved on a 6% buffer gradient TBE sequencing
gel. Lanes TCGA represent a sequencing ladder from an M13 clone containing vaccinia virus DNA and lane
1 contains undigested DNA probe. The length of the protected fragments were determined by counting the number
of nucleotides in the parallel sequencing ladder starting from the 5' end of the universal sequencing primer. C.
Primer extension. A 21 base oligonucleotide was 5' labelled with 'y -_32P]-ATP and polynucleotide kinase and
hybridized to early (lane 2) or late (lane 3) virus mRNA. Extension from the oligonucleotide was performed
with reverse transcriptase and products were resolved on a 6% buffer gradient sequencing gel. An M13 clone
containing vaccinia virus DNA sequenced from universal primer was used as the size ladder (lanes TCGA).
Lane 1, [32P]-labelled oligonucleotide.
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s MRRLLTGCLLSSARPLKSF&LL MSSSLP KQATLARFFTSMKNKPTEGTPSP SKHMLEDNVSGEEE&TKKLKQTAVTHTVAAP
sp RTVFSQIPRFKQVNQYIRMSTRQSDISNFFI KSENVEVSQSSSDSKNVDGRST SVKL SKHNNH DTQNVERENNIVSEAKKQ
vv MTSLREFRICC CDIYH IRDFI23D
sc SSMGSNFSSIPSSAPSSGVADSPQQSQ1 VGEVE>LSSNNNDHYSSNIPYSEVCEVFN AISSRL IIfRIc]fIKIb ~KNVIPTTYLFINF _
sp KTLGSSSSSSDAVSSNNDSGASTPIPLPI SNARNDKLKGHATFAEMVKAFT E DIMT E FGIL PSTLLACVYLSINEI
vv LIILLI DPtYJtNDK IKLYI EDML QEIf
Sc WPD EAGLELGLGENLLMKS GKSMSQ(LK)D IGDLGEIAMG VQPTMFKPKPL EVFK I RAIITQGKDSQLKK IKRML GI
sp ESD SGLELGIGESII GQTLQq GDLGLVAQTS NQPTMFKPAALT.PFLFDSlCKIA3MSGNQSQNR IIKRL GA
vv:V Mix BY~~~TPffNTEI RKSILTLE SFLTZJS~ ESH KTDI CN
sc EAWLIRSLESFEJLAEK -IIKALLLHDENREDSPDKDVPMDVLESAQQKIFiCQVIaYEIaSCLEHGIMNLDKYCTLRPG *L}K
sp EPMYLIRALEGI$4R4 L EKT ATAQYHADKNG EKLSQQDRIEG EQIL L QLPSYDI[NPHLIEHGf]GTLRETCKL PG
vv DIVVMLIDKtWK RCAGPR NAY RKSILKEI_ENASKQN?JDSI SIS I
sc PTKAI&EVLD FQGE Y&GTDGEIR ENMTERYPEINITDFIQDLDTTKNL VAWDKDQGKLP TF V
sp PTKQISEVLN DQ TEDG VRYPflISVSVSKWKKP V
vvSCDS K PSGS PVSHK%YLKEYIPKAFKt I IVLVDE LP IEY
sCc ,aj,LNDKVKVYNR,RLINITE43TKV3GEFQYATQITTPNLD!g2KEE SVNHS G ESES R
Sp IGD IKVRA L4FDmLyLNnQPLLE PwERF4KImYSMFQPSTGDF1WKHSDQKSIESIEEIESVKDS G S RLV
vv tpSNM i 2t DuFDMTD p 10NE@KD9VE]RIVtjSELTNIS0ESCtTD DALTRK G uI
sc Y GV D GAYY OF G E T KATFVFD SSAEPDVIEPTTL
sp "DLSGVGIDS"DQ I E,GAYY KG CRTS*L DTETVScIp GTSEEDI KDFYANSDRPAHQPDV EPKYL
vv EGS GAYYGK KI ESg|WM 1 C QNL PKKIPEWLVNKIYIP VVEDP
sc FEVLTADLSPIYKAGSATF D P IRED D7flSSDQ YENQ SHMQN
sp WEVLAADmLSPVYKAAIGYVQED I PR IRE DEWSEQVSEFY 2VAYSQKEKEGSPAAEDY
vv KQSQIWEIlg GAEFTSSKSHT EVHLNMRLNI
Figure 4 Alignment of the amino acid sequences of DNA ligases from vaccinia virus (vv), S. ponibe (sp) and
S. cerevisiae (sc) made using programme MULTALIGN (42). The position of the conserved catalytic lysine
from the ATP binding site is marked by an asterisk. Amino acids which are identical in vaccinia virus and either
or both yeast sequences are boxed.
well as in T4 and T7 DNA ligases. In the E. coli enzyme, which uses NAD rather than
ATP as cofactor, this site is less conserved. The most highly conserved region is very
close to the carboxy terminus and is rich in basic amino acids. Over a 16 amino acid region
the vaccinia protein shares identity with S. pombe at 15 positions with S. cerevisiae at
14 positions with a conservative isoleucine to valine change at one of the two divergent
amino acids. This region is also well conserved in T4 with 6 identical residues and several
conservative changes. The high conservation of this region suggests it plays some critical
role in DNA ligase function, and its basic composition is consistent with an interaction
with the DNA substrate. Comparisons of the vaccinia virus protein with prokaryotic DNA
ligases using DIAGON (date not shown) showed very little similarity with only short
conserved domains. This is not surprising since the prokaryotic DNA ligases are themselves
divergent with little homology.
DISCUSSION
The nucleotide sequence of a vaccinia virus gene which maps in the SalI F fragment and
which potentially encodes a polypeptide of 63.3 kD is presented. The deduced amino acid
sequence of the open reading frame has extensive similarity to DNA ligases of S. pombe
and S. cervisiae but poor similarity to prokaryotic DNA ligases outside a few highly
conserved domains. This provides direct evidence that vaccinia virus encodes a DNA ligase
and supports early data (26) showing a 13-fold increase in DNA ligase activity in the
cytoplasm of vaccinia virus-infected cells. Spadari (1976) concluded that the increase in
DNA ligase activity was probably not virus-encoded since the enzyme had similar
biochemical characteristics to cellular DNA ligase I, but may be attributable to enhanced
leakage of the nuclear enzyme into the cytoplasm of virus infected cells. The high structural
relatedness of the predicted vaccinia virus protein to known DNA ligases is alone probably
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sufficient to conclude that the protein is a DNA ligase, but this conclusion is supported
by the observed increase in ligase activity in virus-infected cells and our own biochemical
data demonstrating that the encoded protein possesses DNA ligase activity (Kerr and Smith,
submitted for publication).
The amino acid sequence of this vaccinia enzyme is the first reported primary structure
of a 'mammalian' DNA ligase. It is also the only example of a eukaryotic virus encoding
a DNA ligase, although other large DNA viruses which replicate in the cytoplasm, such
as African Swine Fever Virus, probably encode this enzyme. Although much is known
of mammalian DNA ligases the genes encoding these enzymes have not been mapped.
The search for these genes has received extra importance with the demonstration that the
genetically inheritable disease, Bloom's syndrome, is associated with a defect in DNA
ligase I resulting in enzyme thermolability and decreased activity (54,55,34). This search
may be aided by the nucleotide and deduced amino acid sequence of the vaccinia DNA
ligase. The highly conserved amino acid domains in the carboxy-terminal region may be
used to design synthetic oligopeptides which could be used to raise antisera to screen
expression vector libraries containing mammalian cDNAs. Alternatively, mixtures of
synthetic oligonucleotides representing the sequences from these domains could be used
in polymerase chain reactions to amplify and subsequently clone the ligase gene(s).
Transcriptional analyses demonstrate that the vaccinia DNA ligase gene is transcribed
early during infection. This finding was contradictory to what may have been predicted
from inspection of the nucleotide sequence proximal to the translational start site. At this
position there is a sequence TAAATG characteristic of transcriptional start sites of late
vaccinia genes and is immediately preceded by two overlapping early transcriptional
termination signals (TTTTTTTAT). Perversely, the sequence T7NT is also present just
upstream of the TAAATG motif of two of the strongest late poxvirus promoters known
(46,48,49). The function of these early transcriptional termination signals at this position
is unclear, but it is unlikely to be the prevention of early transcripts running through the
ligase promoter from upstream and thereby interfering with transcription initiating from
the ligase promoter, since transcription termination induced by this signal occurs
approximately 50 nucleotides downstream. Surprisingly, there are no early transcription
termination signals near the 3' end of the DNA ligase gene. Instead the early mRNAs
terminate after the first or second gene downstream (SalF 16R and SalF 17R) which are
transcribed in the same direction. Consequently, the DNA ligase mRNAs are potentially
polycistronic.
Mapping of the 5' end of transcripts from the DNA ligase gene by S1 nuclease protection
showed a major cluster of 5' ends at, or just downstream of, the TAAATG motif, with
the strongest signals at the T and G nucleotides of the ATG codon. There are also three
other very minor start sites downstream within the first 80 nucleotides of the open reading
frame. The abundance of these minor start sites was even lower when analysed by primer
extension and are not discernible on the autoradiograph shown but only after prolonged
exposure. The significance of these minor, smaller transcripts is unclear but translation
from them would give rise to a protein lacking the amino terminal 54 amino acids. Primer
extension confirmed that the 5' end of >95% of the mRNAs mapped to near the TAAATG
motif but placed the major 5' end five nucleotides upstream of the position determined
by S1 nuclease protection. This is possibly due to nibbling of the terminal nucleotides
by S1 nuclease. Alternatively, it could be due to extra A nucleotides on the 5' end of
mRNA between the cap structure and AUG codon and might explain how the 5' terminal
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nucleotide, predicted to be predominantly T from the primer extension result, could be
A (or G) as shown from analysis of the cap structure of total early virus mRNA (56).
The TAAATG motif is therefore not exclusively a start site for late vaccinia mRNAs.
A similar result was obtained with gene 5 in the HindHI D fragment which contains this
motif at this site of initiation of transcription early during infection (57).
DNA ligase can now be added to the list of enzymes known to be encoded by vaccinia
virus. Other virus encoded enzymes involved in DNA metabolism are DNA polymerase,
topoisomerase, ribonucleotide reductase and thymidine kinase. In addition a single strand-
specific nuclease and nicking-joining enzyme are packaged in the virion and likely to be
virus-encoded. Probably this cytoplasmically replicating virus contains a complete DNA
replication system that may function independently of host enzymes. In view of this the
existence of a virus-coded DNA ligase might be predicted. However, vaccinia contains
two other enzymes with DNA strand sealing activity (topoisomerase and nicking-joining
enzyme) and models for virus DNA replication have been proposed which do not require
a conventional DNA ligase (58,59). In one model the linear double stranded DNA genome
with covalently closed hairpin ends is nicked on one strand near one, or both, terminal
hairpins to provide a 3' OH from which polymerisation may initiate. Elongation proceeds
around the terminal hairpin, down the linear genome and around the opposite hairpin to
produce concatemeric DNA molecules by a strand displacement mechanism. This model
does not require, but may use, lagging strand synthesis. An alternative model requires
the use of short primers, lagging strand synthesis and a DNA ligase (60). Resolution of
concatemeric junctions into closed hairpins can be accomplished by nicking-joining enzyme
(so named to distinguish it from topoisomerase I, nicking-closing) (14). While the existence
of a virus DNA ligase does not establish either mechanism it is consistent with lagging
strand synthesis for which some evidence has been presented (61,62). An alternative, or
additional, function of the virus DNA ligase could be in DNA recombination. In
bacteriophage T4 replication, the processes of DNA replication and recombination are
dependent upon each other and DNA ligase is essential for both activities (63). Similarly,
vaccinia virus DNA replication and recombination are linked and no conditional lethal
mutants have been described which are defective in only one of these processes. No
conditional lethal mutant has been assigned to the DNA ligase gene. An exciting possible
explanation is that a temperature sensitive DNA ligase may result in a recombination
defective phenotype and therefore marker rescue at the nonpermissive temperature would
not occur. The isolation of such a mutant or the construction of a virus expressing DNA
ligase conditionally from an inducible promoter (64, Rodriguez and Smith, in preparation)
will be valuable tools in determining if DNA ligase is essential and in elucidating its role
in DNA replication and recombination.
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